Analytical and clinical validation of a novel in-house deep-sequencing method for minimal residual disease monitoring in a phase II trial for multiple myeloma

作者:Martinez Lopez J*; Sanchez Vega B; Barrio S; Cuenca I; Ruiz Heredia Y; Alonso R; Rapado I; Marin C; Cedena M T; Paiva B; Puig N; Mateos M V; Ayala R; Hernandez M T; Jimenez C; Rosinol L; Martinez R; Teruel A I; Gutierrez N; Martin Ramos M L; Oriol A; Bargay J; Blade J; San Miguel J; Garcia Sanz R; Lahuerta J J
来源:Leukemia, 2017, 31(6): 1446-1449.
DOI:10.1038/leu.2017.58